- This just in July 30
Pharmaceutical giant Pfizer Inc. agreed Wednesday to buy the vaccines unit of Baxter International Inc. in a $635 million deal, Reuters reports.
Through the acquisition, Pfizer will have access to Baxter's meningitis vaccine and its encephalitis vaccine, both of which are currently available outside of the United States. Pfizer will also gain access to part of Baxter's vaccine production facility in Austria.
Pfizer's global vaccines business reported sales of $1.1 billion in the second quarter, while Baxter's international vaccines sales totaled $110 million in the same timeframe. The deal is expected to close by the end of the year.- -
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- Germany has a serious wolf problem
- There's a raging Islamic insurgency in Thailand's strangest party town
- 10 things you need to know today: December 28, 2014
- How I lost all my money
- China's leader is telling the People's Liberation Army to prepare for war
- 43 TV shows to watch in 2014
- How academia's liberal bias is killing social science
- Why we can't educate racism away
- The best performances we saw in 2014
- New York City's police unions need to get a grip
Subscribe to the Week